Search research articles
Contact Us
Filters
Showing results (51-60 of 265) with videos related to
Page
of 27
Sort By:
Cells
|
May 14, 2022
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
Öykü Gönül Geyik, Giulia Anichini, Engin Ulukaya, et al.
Journal of Hepatology
|
May 20, 2022
Metabolic reprogramming in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Frontiers in Cell and Developmental Biology
|
January 24, 2025
Organoids and spheroids: advanced <i>in vitro</i> models for liver cancer research
Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, et al.
Clinical and Experimental Medicine
|
June 17, 2015
Management strategies for hepatocellular carcinoma: old certainties and new realities
Gianluigi Mazzoccoli, Roberto Tarquini, Alice Valoriani, et al.
Hepatology (Baltimore, Md.)
|
September 9, 2018
A Large Rheumatoid Nodule Mimicking Hepatic Malignancy
Claudia Campani, Maria Guido, Stefano Colagrande, et al.
Internal and Emergency Medicine
|
February 7, 2021
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver
Stefano Gitto, Claudia Campani, Sergio Generini, et al.
Molecular and Clinical Oncology
|
April 29, 2017
Sudden cardiac death in a patient with advanced hepatocellular carcinoma with good response to sorafenib treatment: A case report with literature analysis
Linda Calistri, Cesare Cordopatri, Cosimo Nardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 4, 2022
Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice
Elvire Desjonqueres, Claudia Campani, Fabio Marra, et al.
Journal of Cell Science
|
March 5, 2004
Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A
Michaela Luconi, Vinicio Carloni, Fabio Marra, et al.
Current Pharmaceutical Design
|
December 11, 2013
The metabolic syndrome and chronic liver disease
Matteo Rosselli, Sophie Lotersztajn, Francesco Vizzutti, et al.
Page
of 27
Search research articles
Search
Showing results (51-60 of 265) with videos related to
Sort By:
Page
of 27
Cells
|
May 14, 2022
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
Öykü Gönül Geyik, Giulia Anichini, Engin Ulukaya, et al.
Journal of Hepatology
|
May 20, 2022
Metabolic reprogramming in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Frontiers in Cell and Developmental Biology
|
January 24, 2025
Organoids and spheroids: advanced <i>in vitro</i> models for liver cancer research
Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, et al.
Clinical and Experimental Medicine
|
June 17, 2015
Management strategies for hepatocellular carcinoma: old certainties and new realities
Gianluigi Mazzoccoli, Roberto Tarquini, Alice Valoriani, et al.
Hepatology (Baltimore, Md.)
|
September 9, 2018
A Large Rheumatoid Nodule Mimicking Hepatic Malignancy
Claudia Campani, Maria Guido, Stefano Colagrande, et al.
Internal and Emergency Medicine
|
February 7, 2021
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver
Stefano Gitto, Claudia Campani, Sergio Generini, et al.
Molecular and Clinical Oncology
|
April 29, 2017
Sudden cardiac death in a patient with advanced hepatocellular carcinoma with good response to sorafenib treatment: A case report with literature analysis
Linda Calistri, Cesare Cordopatri, Cosimo Nardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 4, 2022
Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice
Elvire Desjonqueres, Claudia Campani, Fabio Marra, et al.
Journal of Cell Science
|
March 5, 2004
Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A
Michaela Luconi, Vinicio Carloni, Fabio Marra, et al.
Current Pharmaceutical Design
|
December 11, 2013
The metabolic syndrome and chronic liver disease
Matteo Rosselli, Sophie Lotersztajn, Francesco Vizzutti, et al.
Page
of 27